HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Systematic review of immunoglobulin use in paediatric neurological and neurodevelopmental disorders.

AbstractAIM:
A systematic literature review of intravenous immunoglobulin (IVIG) treatment of paediatric neurological conditions was performed to summarize the evidence, provide recommendations, and suggest future research.
METHOD:
A MEDLINE search for articles reporting on IVIG treatment of paediatric neuroinflammatory, neurodevelopmental, and neurodegenerative conditions published before September 2015, excluding single case reports and those not in English. Owing to heterogeneous outcome measures, meta-analysis was not possible. Findings were combined and evidence graded.
RESULTS:
Sixty-five studies were analysed. IVIG reduces recovery time in Guillain-Barré syndrome (grade B). IVIG is as effective as corticosteroids in chronic inflammatory demyelinating polyradiculoneuropathy (grade C), and as effective as tacrolimus in Rasmussen syndrome (grade C). IVIG improves recovery in acute disseminated encephalomyelitis (grade C), reduces mortality in acute encephalitis syndrome with myocarditis (grade C), and improves function and stabilizes disease in myasthenia gravis (grade C). IVIG improves outcome in N-methyl-d-aspartate receptor encephalitis (grade C) and opsoclonus-myoclonus syndrome (grade C), reduces cataplexy symptoms in narcolepsy (grade C), speeds recovery in Sydenham chorea (grade C), reduces tics in selected cases of Tourette syndrome (grade D), and improves symptoms in paediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (grade B).
INTERPRETATION:
IVIG is a useful therapy in selected neurological conditions. Well-designed, prospective, multi-centre studies with standardized outcome measures are required to compare treatments.
AuthorsJonathan Gadian, Emma Kirk, Kate Holliday, Ming Lim, Michael Absoud
JournalDevelopmental medicine and child neurology (Dev Med Child Neurol) Vol. 59 Issue 2 Pg. 136-144 (Feb 2017) ISSN: 1469-8749 [Electronic] England
PMID27900773 (Publication Type: Journal Article, Review, Systematic Review)
Copyright© 2016 Mac Keith Press.
Chemical References
  • Immunoglobulins
  • Immunologic Factors
Topics
  • Humans
  • Immunoglobulins (therapeutic use)
  • Immunologic Factors (therapeutic use)
  • MEDLINE (statistics & numerical data)
  • Nervous System Diseases (therapy)
  • Neurodevelopmental Disorders (therapy)
  • Pediatrics

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: